GDPR
GENERAL DATA PROTECTION REGULATORY (GDPR)
COMPLIANCE WHITE PAPER
Introduction
As a developer, manufacturer, and supplier of non-invasive medical devices, LLC "LABORATORY OF SYSTEMIC BLOOD RESEARCH "BIOPROMIN" is committed to delivering high-quality medical products that make healthcare more accessible and affordable worldwide. Since our founding in 2011, we have worked to provide not only medical devices and industry solutions, but also to embed our corporate values into every aspect of the company. To serve clients better, «BIOPROMIN» follows the most stringent international and CE manufacturing and quality control standards across our facilities, ensuring efficiency and traceability throughout the entire process.
This White Paper aims to provide our clients and stakeholders information to understand the LLC "LABORATORY OF SYSTEMIC BLOOD RESEARCH "BIOPROMIN" privacy policy better. Specifically, this White Paper describes how BIOPROMIN implements its privacy policy to collect, store, transfer and delete data in the process of product design, manufacture, sales and use.
With the effective date of General Data Protection Regulation (GDPR) of European Union, BIOPROMIN has been taking practical actions to comply with GDPR compliance frameworks. BIOPROMIN is a leading practitioner at the forefront of industry compliance practices all along. In this White Paper, it will help you to understand:
• BIOPROMIN overall privacy protection policy, including guiding principles adopted by headquarters and its subsidiaries;
• BIOPROMIN GDPR compliance programme illustrating the corporate governance and internal controls with regards to the considerations of privacy protection;
• The mechanism of BIOPROMIN products on how to collect, store, transfer and delete data.
Disclaimer:
This White Paper is provided solely for informational purposes and aimed to help existing and prospective business partners understand how BIOPROMIN may facilitate your compliance with the GDPR. It shall not be construed or used as legal advice about the GDPR, its implementing rules or regulatory guidelines. The White Paper summarises BIOPROMIN GDPR compliance measures and status as of the release date of this document and is subject to future changes without prior notice.
a) For software USPIH:
The USPIH software allows you to export data from the results of a patient examination to a paper medium and files of the HTML or PDF format. This enables you to realize the right to data portability.
b) For DeepScan and related software:
The software allows you to export data from the results of a patient examination onto paper and PDF files with the subsequent transfer of files via email. This enables you to realize the right to data portability.
The software allows you to remotely connect the transfer of the results of your research to the doctor's cloud account and the function of displaying the test results in the doctor's account in real-time is implemented.
This allows you to realize the right to data portability.